Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin A Kabelitz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 13, 2026
Interpreting Survival Models in Post-TIPS Hepatic EncephalopathyMartin A Kabelitz, Lisa Sandmann, Benjamin Maasoumy
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 9, 2025
ReplyMartin A Kabelitz, Lisa Sandmann, Benjamin Maasoumy
Alimentary Pharmacology & Therapeutics|February 2, 2026
Letter on: 'Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS'. Authors' ReplyChristian Labenz, Martin A Kabelitz, Simon J Gairing, et al.
United European Gastroenterology Journal|August 9, 2025
Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt PlacementLisa Sandmann, Julius F M Egge, Anja Tiede, et al.
Zeitschrift Fur Gastroenterologie|March 24, 2026
Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease - Data from the German SLD-RegistryAndreas Geier, Martin A Kabelitz, Monika Rau, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
No value of non-selective beta-blockers after TIPS-insertionAnja Tiede, Lena Stockhoff, Hannah Rieland, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis DLisa Sandmann, Mathias Jachs, Tammo L Tergast, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2025
Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort StudyMartin A Kabelitz, Lisa Sandmann, Michael Praktiknjo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 13, 2026
Interpreting Survival Models in Post-TIPS Hepatic EncephalopathyMartin A Kabelitz, Lisa Sandmann, Benjamin Maasoumy
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 9, 2025
ReplyMartin A Kabelitz, Lisa Sandmann, Benjamin Maasoumy
Alimentary Pharmacology & Therapeutics|February 2, 2026
Letter on: 'Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS'. Authors' ReplyChristian Labenz, Martin A Kabelitz, Simon J Gairing, et al.
United European Gastroenterology Journal|August 9, 2025
Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt PlacementLisa Sandmann, Julius F M Egge, Anja Tiede, et al.
Zeitschrift Fur Gastroenterologie|March 24, 2026
Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease - Data from the German SLD-RegistryAndreas Geier, Martin A Kabelitz, Monika Rau, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
No value of non-selective beta-blockers after TIPS-insertionAnja Tiede, Lena Stockhoff, Hannah Rieland, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis DLisa Sandmann, Mathias Jachs, Tammo L Tergast, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2025
Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort StudyMartin A Kabelitz, Lisa Sandmann, Michael Praktiknjo, et al.
Pageof 1